CN Stock MarketDetailed Quotes

300122 Chongqing Zhifei Biological Products

Watchlist
  • 27.82
  • +3.61+14.91%
Market Closed Sep 27 15:00 CST
66.60BMarket Cap11.02P/E (TTM)

Chongqing Zhifei Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
125.16%8.84B
Operating revenue
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
125.16%8.84B
Other operating revenue
4,427.67%115.66M
----
5.86%4.08M
----
18.55%2.55M
----
-83.58%3.85M
----
-84.84%2.15M
----
Total operating cost
-20.24%15.28B
8.45%9.32B
48.35%43.09B
47.80%31.15B
38.69%19.16B
32.19%8.6B
57.31%29.05B
78.26%21.07B
107.35%13.82B
135.96%6.5B
Operating cost
-22.23%13.39B
8.22%8.43B
52.29%38.67B
51.56%28.17B
41.00%17.22B
32.79%7.79B
62.56%25.4B
85.16%18.59B
122.40%12.21B
152.91%5.86B
Operating tax surcharges
-20.56%88.92M
0.96%50.14M
34.87%238.75M
37.39%175.03M
31.81%111.93M
35.60%49.66M
30.90%177.02M
30.75%127.39M
36.93%84.92M
123.51%36.63M
Operating expense
-5.90%1.12B
10.83%495.13M
24.04%2.77B
25.56%1.84B
24.71%1.19B
23.18%446.75M
21.82%2.24B
19.91%1.47B
22.18%950.67M
33.36%362.68M
Administration expense
10.60%202.93M
38.95%110.95M
5.05%393.03M
-0.85%273.5M
6.87%183.49M
10.80%79.85M
24.63%374.13M
37.30%275.84M
33.03%171.7M
26.19%72.07M
Financial expense
-6.35%20.59M
-69.57%5.96M
242.20%47.22M
379.40%35.21M
217.72%21.99M
178.72%19.6M
-36.77%13.8M
-62.63%7.34M
-82.34%6.92M
-76.84%7.03M
-Interest expense (Financial expense)
24.11%49.23M
15.25%24.48M
51.98%81M
37.45%57.61M
41.25%39.66M
138.10%21.24M
-5.07%53.3M
-22.39%41.91M
-43.40%28.08M
-68.22%8.92M
-Interest Income (Financial expense)
-52.04%-47.18M
-125.95%-29.66M
-47.40%-67.94M
-36.55%-47.1M
-44.64%-31.03M
-7.40%-13.13M
25.01%-46.09M
20.18%-34.49M
-33.32%-21.45M
-285.63%-12.22M
Research and development
5.60%461.35M
9.41%234.08M
13.38%968.47M
6.76%648.54M
12.68%436.88M
32.98%213.96M
54.56%854.16M
152.77%607.5M
138.26%387.72M
161.12%160.89M
Credit Impairment Loss
-25.14%-396.67M
-126.58%-340.79M
16.32%-352.71M
-122.44%-567.84M
-58.63%-316.98M
-11.84%-150.41M
-120.78%-421.51M
-59.90%-255.28M
-78.87%-199.83M
-111.69%-134.48M
Asset Impairment Loss
80.88%-12.01M
97.03%-1.03M
-186.58%-311.99M
-264.91%-115.14M
-620.30%-62.79M
-223.84%-34.59M
-17.67%-108.87M
-567.91%-31.55M
-114.80%-8.72M
4,321.50%27.93M
Other net revenue
-25.38%-397.6M
-87.50%-335.67M
1.28%-449.97M
-109.96%-489.7M
-93.03%-317.11M
-161.21%-179.02M
-145.10%-455.79M
-75.71%-233.24M
-56.25%-164.28M
-13.19%-68.53M
Asset deal income
-99.78%95.41K
----
618,276.31%41.37M
280,967.56%43.05M
281,852.30%43.19M
--41.78K
-82.90%6.69K
-14.47%15.32K
-14.47%15.32K
----
Other revenue
-43.60%10.99M
3.78%6.16M
132.43%173.36M
180.39%150.23M
-55.98%19.48M
-84.40%5.93M
-27.63%74.59M
38.41%53.58M
166.73%44.25M
1,030.69%38.02M
Operating profit
-48.08%2.58B
-27.54%1.74B
7.02%9.37B
17.18%7.64B
13.57%4.97B
5.62%2.4B
-27.01%8.76B
-34.01%6.52B
-31.69%4.37B
104.45%2.27B
Add:Non operating Income
218.68%38.09K
83.63%18.52K
-44.80%337.69K
-89.19%15.96K
-91.29%11.95K
681.73%10.09K
230.76%611.76K
73.93%147.64K
191.58%137.18K
-39.42%1.29K
Less:Non operating expense
26.00%6.46M
-36.55%2.92M
-23.18%31.48M
-50.39%16.79M
-75.46%5.12M
-27.15%4.6M
-40.69%40.98M
-30.89%33.84M
-16.76%20.88M
-27.68%6.31M
Total profit
-48.16%2.57B
-27.53%1.73B
7.16%9.34B
17.53%7.62B
13.99%4.96B
5.71%2.39B
-26.93%8.72B
-34.02%6.48B
-31.75%4.35B
105.49%2.26B
Less:Income tax cost
-51.83%338.38M
-23.38%276.02M
7.92%1.27B
24.37%1.09B
12.55%702.41M
5.89%360.26M
-31.55%1.18B
-38.42%875.41M
-29.69%624.11M
108.63%340.22M
Net profit
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
Net profit from continuing operation
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
Net profit of parent company owners
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
Earning per share
Basic earning per share
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
104.93%1.2017
Diluted earning per share
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
104.93%1.2017
Other composite income
Total composite income
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
Total composite income of parent company owners
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -25.31%18.26B2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B125.16%8.84B
Operating revenue -25.31%18.26B2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B125.16%8.84B
Other operating revenue 4,427.67%115.66M----5.86%4.08M----18.55%2.55M-----83.58%3.85M-----84.84%2.15M----
Total operating cost -20.24%15.28B8.45%9.32B48.35%43.09B47.80%31.15B38.69%19.16B32.19%8.6B57.31%29.05B78.26%21.07B107.35%13.82B135.96%6.5B
Operating cost -22.23%13.39B8.22%8.43B52.29%38.67B51.56%28.17B41.00%17.22B32.79%7.79B62.56%25.4B85.16%18.59B122.40%12.21B152.91%5.86B
Operating tax surcharges -20.56%88.92M0.96%50.14M34.87%238.75M37.39%175.03M31.81%111.93M35.60%49.66M30.90%177.02M30.75%127.39M36.93%84.92M123.51%36.63M
Operating expense -5.90%1.12B10.83%495.13M24.04%2.77B25.56%1.84B24.71%1.19B23.18%446.75M21.82%2.24B19.91%1.47B22.18%950.67M33.36%362.68M
Administration expense 10.60%202.93M38.95%110.95M5.05%393.03M-0.85%273.5M6.87%183.49M10.80%79.85M24.63%374.13M37.30%275.84M33.03%171.7M26.19%72.07M
Financial expense -6.35%20.59M-69.57%5.96M242.20%47.22M379.40%35.21M217.72%21.99M178.72%19.6M-36.77%13.8M-62.63%7.34M-82.34%6.92M-76.84%7.03M
-Interest expense (Financial expense) 24.11%49.23M15.25%24.48M51.98%81M37.45%57.61M41.25%39.66M138.10%21.24M-5.07%53.3M-22.39%41.91M-43.40%28.08M-68.22%8.92M
-Interest Income (Financial expense) -52.04%-47.18M-125.95%-29.66M-47.40%-67.94M-36.55%-47.1M-44.64%-31.03M-7.40%-13.13M25.01%-46.09M20.18%-34.49M-33.32%-21.45M-285.63%-12.22M
Research and development 5.60%461.35M9.41%234.08M13.38%968.47M6.76%648.54M12.68%436.88M32.98%213.96M54.56%854.16M152.77%607.5M138.26%387.72M161.12%160.89M
Credit Impairment Loss -25.14%-396.67M-126.58%-340.79M16.32%-352.71M-122.44%-567.84M-58.63%-316.98M-11.84%-150.41M-120.78%-421.51M-59.90%-255.28M-78.87%-199.83M-111.69%-134.48M
Asset Impairment Loss 80.88%-12.01M97.03%-1.03M-186.58%-311.99M-264.91%-115.14M-620.30%-62.79M-223.84%-34.59M-17.67%-108.87M-567.91%-31.55M-114.80%-8.72M4,321.50%27.93M
Other net revenue -25.38%-397.6M-87.50%-335.67M1.28%-449.97M-109.96%-489.7M-93.03%-317.11M-161.21%-179.02M-145.10%-455.79M-75.71%-233.24M-56.25%-164.28M-13.19%-68.53M
Asset deal income -99.78%95.41K----618,276.31%41.37M280,967.56%43.05M281,852.30%43.19M--41.78K-82.90%6.69K-14.47%15.32K-14.47%15.32K----
Other revenue -43.60%10.99M3.78%6.16M132.43%173.36M180.39%150.23M-55.98%19.48M-84.40%5.93M-27.63%74.59M38.41%53.58M166.73%44.25M1,030.69%38.02M
Operating profit -48.08%2.58B-27.54%1.74B7.02%9.37B17.18%7.64B13.57%4.97B5.62%2.4B-27.01%8.76B-34.01%6.52B-31.69%4.37B104.45%2.27B
Add:Non operating Income 218.68%38.09K83.63%18.52K-44.80%337.69K-89.19%15.96K-91.29%11.95K681.73%10.09K230.76%611.76K73.93%147.64K191.58%137.18K-39.42%1.29K
Less:Non operating expense 26.00%6.46M-36.55%2.92M-23.18%31.48M-50.39%16.79M-75.46%5.12M-27.15%4.6M-40.69%40.98M-30.89%33.84M-16.76%20.88M-27.68%6.31M
Total profit -48.16%2.57B-27.53%1.73B7.16%9.34B17.53%7.62B13.99%4.96B5.71%2.39B-26.93%8.72B-34.02%6.48B-31.75%4.35B105.49%2.26B
Less:Income tax cost -51.83%338.38M-23.38%276.02M7.92%1.27B24.37%1.09B12.55%702.41M5.89%360.26M-31.55%1.18B-38.42%875.41M-29.69%624.11M108.63%340.22M
Net profit -47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B
Net profit from continuing operation -47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B
Net profit of parent company owners -47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B
Earning per share
Basic earning per share -47.48%0.9322-28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538104.93%1.2017
Diluted earning per share -47.48%0.9322-28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538104.93%1.2017
Other composite income
Total composite income -47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B
Total composite income of parent company owners -47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data